Literature DB >> 20148403

Can size alone explain some of the differences in toxicity between beta-amyloid oligomers and fibrils?

Ben Keshet1, In Hong Yang, Theresa A Good.   

Abstract

beta-Amyloid (Abeta) peptide is believed to play a key role in the mechanism of Alzheimer's disease (AD). Abeta tends to aggregate to form amyloid fibrils. A variety of evidence indicates that Abeta aggregates are toxic in vitro and in vivo. An early "Abeta hypothesis" postulated that AD was the consequence of neuron death induced by insoluble deposits of large Abeta fibrils. Newer findings indicate that small soluble Abeta oligomers are the neurotoxic species, yet their structure is still unknown. Many researchers have tried to probe the differences in molecular structure between Abeta oligomers, protofibrils, and fibrils that give rise to their unique toxicities, but with limited success. In this report, we examine the hypothesis that differences in the toxicity of different aggregated Abeta species are the result of differences in species concentration and diffusivity. Using a simple mathematical analysis based on the assumption of a diffusion-limited reaction, we demonstrate that near 10-fold differences in toxicity between spherical oligomers and fibrils can be explained from size and concentration arguments. While this work does not suggest that Abeta oligomers and fibrils have identical molecular structures, it highlights the possibility that simple physical phenomena may contribute to the biological processes induced by Abeta.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148403      PMCID: PMC2935630          DOI: 10.1002/bit.22691

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  23 in total

1.  Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

Authors:  T H Huang; D S Yang; N P Plaskos; S Go; C M Yip; P E Fraser; A Chakrabartty
Journal:  J Mol Biol       Date:  2000-03-17       Impact factor: 5.469

2.  Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy.

Authors:  Michael R Nichols; Melissa A Moss; Dana Kim Reed; Wen-Lang Lin; Rajendrani Mukhopadhyay; Jan H Hoh; Terrone L Rosenberry
Journal:  Biochemistry       Date:  2002-05-14       Impact factor: 3.162

3.  The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy.

Authors:  W B Stine; S W Snyder; U S Ladror; W S Wade; M F Miller; T J Perun; T F Holzman; G A Krafft
Journal:  J Protein Chem       Date:  1996-02

4.  Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway.

Authors:  Sungmun Lee; Erik J Fernandez; Theresa A Good
Journal:  Protein Sci       Date:  2007-02-27       Impact factor: 6.725

5.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 6.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.

Authors:  D Allan Butterfield
Journal:  Free Radic Res       Date:  2002-12

7.  Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: application to Abeta(1-40) fibrillogenesis.

Authors:  Wei Qi; Aming Zhang; Dhara Patel; Sungmun Lee; Jamie L Harrington; Liming Zhao; David Schaefer; Theresa A Good; Erik J Fernandez
Journal:  Biotechnol Bioeng       Date:  2008-08-15       Impact factor: 4.530

Review 8.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

9.  Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure.

Authors:  Yuri Sokolov; J Ashot Kozak; Rakez Kayed; Alexandr Chanturiya; Charles Glabe; James E Hall
Journal:  J Gen Physiol       Date:  2006-11-13       Impact factor: 4.086

10.  Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.

Authors:  Rakez Kayed; Elizabeth Head; Floyd Sarsoza; Tommy Saing; Carl W Cotman; Mihaela Necula; Lawrence Margol; Jessica Wu; Leonid Breydo; Jennifer L Thompson; Suhail Rasool; Tatyana Gurlo; Peter Butler; Charles G Glabe
Journal:  Mol Neurodegener       Date:  2007-09-26       Impact factor: 14.195

View more
  7 in total

1.  Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.

Authors:  Ali Reza A Ladiwala; Jeffrey Litt; Ravi S Kane; Darryl S Aucoin; Steven O Smith; Swarnim Ranjan; Judianne Davis; William E Van Nostrand; Peter M Tessier
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

2.  A revisited folding reporter for quantitative assay of protein misfolding and aggregation in mammalian cells.

Authors:  Simpson Gregoire; Inchan Kwon
Journal:  Biotechnol J       Date:  2012-06-27       Impact factor: 4.677

3.  Cis-suppression to arrest protein aggregation in mammalian cells.

Authors:  Simpson Gregoire; Shaojie Zhang; Joseph Costanzo; Kelly Wilson; Erik J Fernandez; Inchan Kwon
Journal:  Biotechnol Bioeng       Date:  2013-10-18       Impact factor: 4.530

4.  Suppressing mutation-induced protein aggregation in mammalian cells by mutating residues significantly displaced upon the original mutation.

Authors:  Simpson Gregoire; Kelly Glitzos; Inchan Kwon
Journal:  Biochem Eng J       Date:  2014-10-15       Impact factor: 3.978

5.  Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition.

Authors:  Franziska Langer; Yvonne S Eisele; Sarah K Fritschi; Matthias Staufenbiel; Lary C Walker; Mathias Jucker
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

Review 6.  The amyloid state of proteins in human diseases.

Authors:  David Eisenberg; Mathias Jucker
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

7.  Decreasing amyloid toxicity through an increased rate of aggregation.

Authors:  Silvia Sonzini; Helen F Stanyon; Oren A Scherman
Journal:  Phys Chem Chem Phys       Date:  2017-01-04       Impact factor: 3.676

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.